Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudication

Journal of Vascular Surgery

Volumn 56, Issue 6, 2012, Pages 1622-1628.e5

  Gresele, Paolo ^a   Migliacci, Rino ^b   Arosio, Enrico ^c   Bonizzoni, Erminio ^d   Minuz, Pietro ^e   Violi, Francesco ^f  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Department of Internal Medicine   (Italy)

^c Division of Vascular Rehabilitation   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF VERONA   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER;

AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; FUNCTIONAL STATUS; HUMAN; INTERMITTENT CLAUDICATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREADMILL ERGOMETRY; WALKING;

EID: 84870242737     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.05.064     Document Type: Article

References (43)

1. C. White Clinical practice Intermittent claudication N Engl J Med 356 2007 1241 1250
2. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G. Fowkes TASC II Working Group Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 45 2007 S5 S67
3. M.E. Widlansky, N. Gokce, J.F. Keaney Jr, J.A. Vita The clinical implications of endothelial dysfunction J Am Coll Cardiol 42 2003 49 1160
4. M.K. Reriani, L.O. Lerman, A. Lerman Endothelial function as a functional expression of cardiovascular risk factors Biomark Med 4 2010 351 360
5. G. Brevetti, F. Piscione, P. Cirillo, G. Galasso, V. Schiano, E. Barbato In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction Atherosclerosis 201 2008 440 446
6. A. Silvestro, F. Scopacasa, G. Oliva, T. de Cristofaro, L. Iuliano, G. Brevetti Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication Atherosclerosis 165 2002 277 283
7. P. Gresele, R. Migliacci, A. Procacci, P. De Monte, E. Bonizzoni Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication Thromb Haemost 97 2007 444 450
8. Heart Protection Study Collaborative Group Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions J Vasc Surg 45 2007 645 654
9. E.R. Mohler 3rd, W.R. Hiatt, M.A. Creager Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease Circulation 108 2003 1481 1486
10. M. Schillinger, M. Exner, W. Mlekusch, J. Amighi, S. Sabeti, M. Muellner Statin therapy improves cardiovascular outcome of patients with peripheral artery disease Eur Heart J 25 2004 742e
11. A. Blum, R. Shamburek The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis Atherosclerosis 203 2009 325 330
12. R.H. Böger, S.M. Bode-Böger, W. Thiele, A. Creutzig, K. Alexander, J.C. Frölich Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease J Am Coll Cardiol 32 1998 1336 1344
13. B.Y. Wang, R.C. Candipan, M. Arjomandi, P.T. Hsiun, P.S. Tsao, J.P. Cooke Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits J Am Coll Cardiol 28 1996 1573 1579
14. A.M. Wilson, R. Harada, N. Nair, N. Balasubramanian, J.P. Cooke l-arginine supplementation in peripheral arterial disease: no benefit and possible harm Circulation 116 2007 188 195
15. S. Hallström, H. Gasser, C. Neumayer, A. Fügl, J. Nanobashvili, A. Jakubowski S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release Circulation 105 2002 3032 3038
16. S. Dragoni, T. Gori, M. Lisi, G. Di Stolfo, A. Pautz, H. Kleinert Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion Arterioscler Thromb Vasc Biol 27 2007 1955 1959
17. S.R. Walker, S. Tennant, S.T. MacSweeney A randomized, double-blind, placebo-controlled, crossover study to assess the immediate effect of sublingual glyceryl trinitrate on the ankle brachial pressure index, claudication, and maximum walking distance of patients with intermittent claudication J Vasc Surg 28 1998 895 900
18. J.R. De Berrazueta, I. Sampedro, M.T. Garcia-Unzueta, J. Llorca, M. Bustamante, J.A. Amado Effect of transdermal nitroglycerin on inflammatory mediators in patients with peripheral atherosclerotic vascular disease Am Heart J 146 2003 E14 E20
19. P. Gresele, S. Momi Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders Cardiovasc Drug Rev 24 2006 148 168
20. C. Napoli, G. Cirino, P. Del Soldato, R. Sorrentino, V. Sica, M. Condorelli Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice Proc Natl Acad Sci U S A 98 2001 2860 2864
21. P. Gresele, S. Marzotti, G. Guglielmini, S. Momi, S. Giannini, P. Minuz Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent Diabetes Care 33 2010 1262 1268
22. V. Kaddai, T. Gonzalez, M. Bolla, Y. Le Marchand-Brustel, M. Cormont The nitric oxide-donating derivative of acetylsalicylic acid, NCX 4016, stimulates glucose transport and glucose transporters translocation in 3T3-L1 adipocytes Am J Physiol Endocrinol Metab 295 2008 E162 E169
23. J.J. Kastelein, E. de Groot Ultrasound imaging techniques for the evaluation of cardiovascular therapies Eur Heart J 29 2008 849 858
24. G.G. Nenci, P. Gresele, G. Ferrari, L. Santoro, F. Gianese Mesoglycan Intermittent Claudication Group Treatment of intermittent claudication with mesoglycan-a placebo-controlled, double-blind study Thromb Haemost 86 2001 1181 1187
25. R.L. Pande, W.R. Hiatt, P. Zhang, N. Hittel, M.A. Creager A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication Vasc Med 15 2010 181 188
26. P. Gresele, R. Migliacci, G. Di Sante, G.G. Nenci CRAMPS Investigator Group Effect of cloricromene on intermittent claudication. A randomized, double-blind, placebo-controlled trial in patients treated with aspirin: effect on claudication distance and quality of life. CRAMPS Investigator Group. Cloricromene Randomized Arteriopathy Multicenter Prospective Study Vasc Med 5 2000 83 89
27. J. Pernow, F. Bohm, E. Beltran, A. Gonon l-arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo J Appl Physiol 95 2003 2218 2222
28. M.W. Lorenz, H.S. Markus, M.L. Bots, M. Rosvall, M. Sitzer Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis Circulation 115 2007 459 467
29. M.L. Bots, M.K. Palmer, S. Dogan, Y. Plantinga, J.S. Raichlen, G.W. Evans Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study J Intern Med 265 2009 698 707
30. E. Lonn, S. Yusuf, V. Dzavik, C. Doris, Q. Yi, S. Smith Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE) Circulation 103 2001 919 925
31. D. Mörtsell, K. Malmqvist, C. Held, T. Kahan Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study J Intern Med 261 2007 472 479
32. O. Iida, S. Nanto, M. Uematsu, T. Morozumi, M. Kitakaze, S. Nagata Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions J Vasc Surg 48 2008 144 149
33. N. Katakami, Y.S. Kim, R. Kawamori, Y. Yamasaki The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the diabetic atherosclerosis prevention by cilostazol (DAPC) study: a randomized trial Circulation 121 2010 2584 2591
34. M.R. Langenfeld, T. Forst, C. Hohberg, P. Kann, G. Lübben, T. Konrad Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study Circulation 111 2005 2525 2531
35. J.M. Dijk, Y. van der Graaf, M.L. Bots, D.E. Grobbee, A. Algra Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study Eur Heart J 27 2006 1971 1978
36. J. Yu, R.D. Rudic, W.C. Sessa Nitric oxide-releasing aspirin decreases vascular injury by reducing inflammation and promoting apoptosis Lab Invest 82 2002 825 832
37. S. Momi, S.C. Pitchford, P.F. Alberti, P. Minuz, P. Del Soldato, P. Gresele Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice Thromb Haemost 93 2005 535 543
38. M. Juonala, J.S. Viikari, T. Laitinen, J. Marniemi, H. Helenius, T. Rönnemaa Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study Circulation 110 2004 2918 2923
39. H.G. Beebe, D.L. Dawson, B.S. Cutler, J.A. Herd, D.E. Strandness Jr, E.B. Bortey A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial Arch Intern Med 159 1999 2041 2050
40. H.C. Flu, J.T. Tamsma, J.H. Lindeman, J.F. Hamming, J.H. Lardenoye A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD Eur J Vasc Endovasc Surg 39 2010 70 86
41. P.J. Touboul, M.G. Hennerici, S. Meairs, H. Adams, P. Amarenco, N. Bornstein Mannheim carotid intima-media thickness consensus (2004-2006) An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European stroke conferences, Mannheim, Germany, 2004, and Brussels, Belgium Cerebrovasc Dis 23 2007 75 80
42. C. Emanueli, S. Van Linthout, M.B. Salis, A. Monopoli, P. Del Soldato, E. Ongini Nitric oxide-releasing aspirin derivative, NCX 4016, promotes reparative angiogenesis and prevents apoptosis and oxidative stress in a mouse model of peripheral ischemia Arterioscler Thromb Vasc Biol 24 2004 2082 2087
43. P.J. Touboul, M.G. Hennerici, S. Meairs, H. Adams, P. Amarenco, N. Bornstein, L. Csiba, M. Desvarieux, S. Ebrahim, M. Fatar, R. Hernandez Hernandez, M. Jaff, S. Kownator, P. Prati, T. Rundek, M. Sitzer, U. Schminke, J.C. Tardif, A. Taylor, E. Vicaut, K.S. Woo, F. Zannad, M. Zureik Mannheim carotid intima-media thickness consensus (2004-2006) An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006 Cerebrovasc Dis 23 2007 75 80